Tesamorelin
Tesamorelin is a stabilized GHRH analog studied for its effects on lipid metabolism and growth hormone–related pathways.
Key Research Points:
Researched for influence on fat metabolism and lipid distribution
Studied in GH-related signaling pathways
Explored in metabolic and body composition research
Longer activity profile compared to some GHRH analogs
Intended for laboratory research use only
Tesamorelin mimics natural human GHRH by binding to pituitary GHRH receptors, triggering pulsatile growth hormone secretion and consequent IGF-1 elevation. This cascade promotes lipolysis (fat breakdown), protein synthesis, and favorable metabolic shifts. In HIV-associated lipodystrophy, daily tesamorelin significantly reduces visceral adipose tissue and improves lipid profiles over 6–12 months. Research also explores tesamorelin’s potential to reduce liver fat in NAFLD patients and enhance cognitive function in older adults by restoring age-related GH/IGF-1 declines.